People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EvolveImmune Therapeutics Holding Company, LLC | — | Biotechnology | Series B | $85.8M | $124.8M | 2023 |
| SIMBA Chain, Inc. | — | Other Technology | Series A | $14.2M | $224.9M | 2019 |
| Markai, Inc. | — | Other Technology | Seed | $3.9M | $71.9M | 2021 |
Ian Taylor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ian Taylor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Miller | 1 | 27 |
| Stephen Bloch | 1 | 15 |
| Bryan Ritchie | 1 | 7 |
| Steve O'Hara | 1 | 6 |
| Derek Yoon | 1 | 4 |
| ANDREW HARRISON | 1 | 4 |
| Hugo Beekman | 1 | 2 |
| HAMENDER AGARWAL | 1 | 2 |
| Alessandra Di Bacco | 1 | 1 |
| Jasmina Marjanovic | 1 | 1 |
| Donmienne Leung | 1 | 1 |
| Gary Neidig | 1 | 1 |
| Timothy Spencer | 1 | 1 |
| Chenyu Ren | 1 | 1 |
| Joel Neidig | 1 | 1 |
| Anjon Roy | 1 | 1 |
| Jaroslaw Nabryzyski | 1 | 1 |
| Denis Patrick | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.